Download Date of Document: March 24, 2017 CURRICULUM VITAE

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
27. Greenblatt DY, Vaccaro AM, Jaskula-Sztul R, Ning L, Haymart M, Kunnimalaiyaan M, Chen H. Valproic acid
activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist. 2007
Aug;12(8):942-51.
28. Greenblatt DY, Cayo M, Ning L, Jaskula-Sztul R, Haymart M, Kunnimalaiyaan M, Chen H. Suberoyl
bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells. J
Gastrointest Surg. 2007 Nov;11(11):1515-20; discussion 1520.
29. Kunnimalaiyaan M, Ndiaye M, Chen H. Neuroendocrine tumor cell growth inhibition by ZM336372 through
alterations in multiple signaling pathways. Surgery. 2007 Dec;142(6):959-64; discussion 959-64. PMCID:
PMC2180346
30. Deming D, Geiger P, Chen H, Vaccaro A, Kunnimalaiyaan M, Holen K. ZM336372, a Raf-1 activator, causes
suppression of proliferation in a human hepatocellular carcinoma cell line. J Gastrointest Surg. 2008
May;12(5):852-7.
31. Ning L, Greenblatt DY, Kunnimalaiyaan M, Chen H. Suberoyl bis-hydroxamic acid activates Notch-1
signaling and induces apoptosis in medullary thyroid carcinoma cells. Oncologist. 2008 Feb;13(2):98-104.
32. Sippel RS, Kunnimalaiyaan M, Chen H. Current management of medullary thyroid cancer. Oncologist. 2008
May;13(5):539-47.
33. Pinchot SN, Pitt SC, Sippel RS, Kunnimalaiyaan M, Chen H. Novel targets for the treatment and palliation of
gastrointestinal neuroendocrine tumors. Curr Opin Investig Drugs. 2008 Jun;9(6):576-82. PMCID: PMC2905744
34. Greenblatt DY, Cayo MA, Adler JT, Ning L, Haymart MR, Kunnimalaiyaan M, Chen H. Valproic acid
activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells. Ann Surg. 2008
Jun;247(6):1036-40. PMCID: PMC2904809
35. Ning L, Jaskula-Sztul R, Kunnimalaiyaan M, Chen H. Suberoyl bishydroxamic acid activates notch1 signaling
and suppresses tumor progression in an animal model of medullary thyroid carcinoma. Ann Surg Oncol. 2008
Sep;15(9):2600-5. PMCID: PMC2737668
36. Platta CS, Greenblatt DY, Kunnimalaiyaan M, Chen H. Valproic acid induces Notch1 signaling in small cell
lung cancer cells. J Surg Res. 2008 Jul;148(1):31-7. PMCID: PMC2900385
37. Ning L, Kunnimalaiyaan M, Chen H. Regulation of cell-cell contact molecules and the metastatic phenotype of
medullary thyroid carcinoma by the Raf-1/MEK/ERK pathway. Surgery. 2008 Dec;144(6):920-4; discussion 9245. PMCID: PMC2639554
38. Adler JT, Hottinger DG, Kunnimalaiyaan M, Chen H. Histone deacetylase inhibitors upregulate Notch-1 and
inhibit growth in pheochromocytoma cells. Surgery. 2008 Dec;144(6):956-61; discussion 961-2. PMCID:
PMC2638099
39. Pinchot SN, Adler JT, Luo Y, Ju J, Li W, Shen B, Kunnimalaiyaan M, Chen H. Tautomycin suppresses growth
and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway. Am J Surg. 2009
Mar;197(3):313-9. PMCID: PMC2664746
40. Adler JT, Hottinger DG, Kunnimalaiyaan M, Chen H. Combination therapy with histone deacetylase inhibitors
and lithium chloride: a novel treatment for carcinoid tumors. Ann Surg Oncol. 2009 Feb;16(2):481-6. PMCID:
PMC2740795
41. Adler JT, Cook M, Luo Y, Pitt SC, Ju J, Li W, Shen B, Kunnimalaiyaan M, Chen H. Tautomycetin and
tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.
Mol Cancer Ther. 2009 Apr;8(4):914-20. PMCID: PMC2670470
42. Goodell CA, Belisle JA, Gubbels JA, Migneault M, Rancourt C, Connor J, Kunnimalaiyaan M, Kravitz R,
Tucker W, Zwick M, Patankar MS. Characterization of the tumor marker muc16 (ca125) expressed by murine
ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies. J Ovarian Res. 2009
Jun 18;2(1):8. PMCID: PMC2708168
43. Pitt SC, Chen H, Kunnimalaiyaan M. Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses
tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors. Ann Surg Oncol. 2009
Oct;16(10):2936-42. PMCID: PMC2917194
44. Pitt SC, Chen H, Kunnimalaiyaan M. Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
J Am Coll Surg. 2009 Jul;209(1):82-8. PMCID: PMC2910111
45. Adler JT, Hottinger DG, Kunnimalaiyaan M, Chen H. Inhibition of the PI3K pathway suppresses hormonal
secretion and limits growth in pheochromocytoma cells. World J Surg. 2009 Nov;33(11):2452-7. PMCID:
PMC3088764
46. Pitt SC, Davis R, Kunnimalaiyaan M, Chen H. AKT and PTEN expression in human gastrointestinal carcinoid
tumors. Am J Transl Res. 2009 Feb 28;1(3):291-9. PMCID: PMC2776321
47. Pinchot SN, Kunnimalaiyaan M, Sippel RS, Chen H. Medullary thyroid carcinoma: targeted therapies and
future directions. J Oncol. 2009;2009:183031. PMCID: PMC2798103
Related documents